Abstract: SH-SY5Y neural cells expressing~a-and 8-opioid receptors were maintained viable in isotonic, sodiumfree buffer in vitro. Intracellular sodium levels were manipulated by various methods, and ligand binding to intact cells was studied. 50 values of 24 and 3,600 nM, respectively. Adenylyl cyclase activities measured in intact cells, at different concentrations of sodium, showed the physiological significance of this ion in signal transduction. Potency of DAMGO in inhibiting the forskolinstimulated adenylyl cyclase activity was significantly higher at lower concentrations of sodium. However, inhibition reached the maximal level only at 50 mM sodium, and typical sigmoidal dose-response curves were obtained only in the presence of 118 mM sodium. Furthermore, even at low or high intracellular sodium levels, DAMGO inhibition of cyclic AMP levels was normal. These results support a role for extracellular sodium in regulating not only the ligand interactions with the receptor, but also the signal transduction through the ,a receptor. Key Words: Sodium-Opioid receptor-Potassium-Amiloride-Monensin-Cyclic AMP.
fists has been studied (Fischel and Medzihradsky, 1981) . In many studies (e.g., Pert and Snyder, 1976) , the effective concentrations of sodium (100-150 mM) that influenced ligand binding to opioid receptors in isolated membranes pointed to extracellular modulation by this cation. In contrast, maximal modulation of opioid receptor binding was observed at sodium concentrations typical for the intracellular milieu (10 mM) (e.g., Nijssen and Childers, 1987) in some studies. In 7315c cells, Puttfarcken et al. (1986) showed an intracellular sodium site by using ligand binding to the~t receptor. In the course of our work on characterization of ligand binding to intact cells, however, we observed that changes in intracellular levels of sodium ([Na]1) under various conditions had no effect on ligand binding parameters. This report thus reexamined the site of sodium action influencing the agonist/antagonist binding and opioid agonist inhibition of adenylyl cyclase activity in intact neural cells. It is particularly important to study a homogeneous population ofreceptor in view of the differential effects of sodium on~.t, 8, and K receptors . Thus, all the studies presented in this report were carried out in SH-SY5Y cells, which express predominantly the /i receptor, and the results were confirmed in C6~t5glial cells that are stably transfected with the cloned ji receptor.
MATERIALS AND METHODS

Materials
[ 3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol ([3H IDAMGO; 60 Ci/mmol) was obtained from Amersham, and [3H]-naltrexone (11 Ci/mmol) was kindly provided by the National Institute on Drug Abuse. [3H]Naloxone (57.5 Ci! The potent modulation of opioid receptor binding in isolated neural membranes by sodium has been well described (e.g., Pert et al., 1973; Simon et al., 1975) , and the mechanism by which sodium enhances the binding of opioid antagonists and reduces that of ago-mmol) was from New England Nuclear, and ethylisopropylamiloride (EIPA) was from Research Biochemical International. Ouabain, monensin, DAMGO, and other biochemicals were purchased from Sigma Chemical Co. Dulbecco's modified Eagle's medium and fetal bovine serum were from GIBCO Laboratories (Grand Island, NY, U.S.A.), and cyclic AMP kits were from Diagnostic Product Corp.
Culture and treatment of cells
As described previously (Carter and Medzihradsky, 1992) , human neuroblastoma SH-SY5Y cells were grown to confluency in Dulbecco' s modified Eagle's medium containing 10% fetal bovine serum. The confluent cells were washed with ice-cold phosphate-buffered saline and lifted off the plate by incubation in Ca 2,Mg2~-free modified Puck's solution for 10 mm. The suspension was pelleted at 200 g for 5 mm, the cell pellet was washed with choline buffer, and the resulting pellet was suspended in the respective isotonic buffers. The basic physiological buffer (20 mM HEPES, 118 mMNaC1, 10 mMglucose, 3.0 mMMgSO 4~7H2O, 1.3 mM CaC12 2H20, pH adjusted to 7.4 with Tris base at 37°C) was modified by replacing sodium with various concentrations of choline chloride in order to prepare isotonic buffers containing 0-118 mM sodium. Buffer containing 118 mM choline chloride has been referred to as the choline buffer throughout the text. In experiments designed to reduce [Na] , by depolarization, retinoic acid-differentiated SH-SY5Y cells were suspended in buffer A (128 mM NaC1, 2.4 mM KC1, 2.0 mMNaHCO3, 3.0 mMMgSO4, 10 mMNa2HPO4, 1.3 mM CaC12, 10 mM glucose, pH 7.4 at 37°C),and 34 mM KC1 was added to induce depolarization.
Ligand binding
Ligand binding to intact cells was carried out in physiological buffers containing various concentrations of sodium in different experiments as described in the legends to the figures. Nonspecific binding was determined with either 1~M DAMGO or naltrexone. The assay medium consisted of 50 il of cell suspension (SH-SY5Y, 60-120~.egof protein; C6ii5, 30~ig of protein), 50~.sl of radiolabeled drug, 50~.el each of ouabain, monensin, and EIPA (in selected experiments), and 300 p~lof buffer medium. After ligand binding reached equilibrium at 37°C(50 mm), contents of the tubes were quickly filtered by using a Brandel cell harvester, and the washed filters were subjected to scintillation counting.
Adenylyl cyclase assay
SH-SY5Y cells were differentiated with 10 1uM retinoic acid for 6 days, collected, and resuspended in isotonic physiological buffers containing 8 mM theophylline and 0, 5, 10, 50, and 118 mM sodium. Cells were preincubated in the respective buffers at 37°Cfor s mm, and the acute inhibition of adenylyl cyclase was assayed as described (Yabaluri and Medzihradsky, 1995 Table 1. 60 mm, samples (0.6-1.0 mg of protein) were centrifuged, and the cell pellet was washed three or four times with cold choline buffer. Subsequently, the washed cell pellets were digested in LiC1 solution (15 mEq/L) with 70% HNO 3 at 70°C. Sodium concentrations in the solutions were determined by flame photometry as described earlier (Fischel and Medzihradsky, 1981) .
Protein determination
Protein in the samples was solubilized in 1 M NaOH prior to estimation by the method of Lowry et al. (1951) , with bovine serum albumin as the standard.
Data analysis
The binding data from saturation experiments were analyzed by the statistical program SYSTAT (Wilkinson, 1988) . Dose-response curves of DAMGO-inhibited adenylyl cyclase activity were fit and plotted using the nonlinear regression program Graphpad.prism (Graph Pad Software, San Diego, CA, U.S.A.).
RESULTS
SH-SY5Y cells were maintained viable in isotonic buffers containing different concentrations of sodium, the ionic strength being kept constant with the addition of choline chloride. Saturation binding of [ 3H]-naltrexone to intact cells showed that sodium increases the affinity of the receptor for the antagonists (Fig. 1) (Fozzard and Kipnis, 1967) . Intact cells were suspended in physiological buffer containing 118 mM NaC1, and 34 mM KC1 was added to decrease [Na]1. As a result, [Na]1 dropped by >60% in comparison with the control cells. Agonist binding was studied under these conditions, and the results are presented in Fig. 4 . In spite of the significant reduction in [Na]1, DAMGO binding was not altered.
[Na]1 (26 ± 5.0 nmol/mg) was comparable to that obtained in the presence of 20-30 mM [Na]0, the concentrations that should have yielded higher binding, if [Na] , was responsible for the modulation of ligand binding.
Agonist binding at increased [Na]
[Na]1 could be raised by incubating the cells suspended in physiological buffer containing 118 mM sodium in the presence of Na + ,K~-ATPase inhibitor, ouabain (30 itM), and the sodium-specific ionophore, monensin (30 1iM), as reported earlier (Connolly and Limbird, 1983; Puttfarcken et al., 1986) . Figure 5a gives the details of [ 3H] DAMGO binding in the presence of various (10-100 itM) concentrations of ouabain and monensin. Monensin and ouabain increased [Na] 1by 3.5-and 1. again without any significant effect on agonist binding (inset to Fig. 5b ).
However, it is possible that monensin and ouabain failed to show any effect on agonist binding, because the [Na], in physiological buffers containing 118 mM sodium was already sufficient to cause the maximal regulation by this cation. Inhibition of agonist binding in our experiments was found to be linear up to 20 mM [Na] 0, which corresponded to -~20 nmol/mg [Na], (Fig. 3) . It was thought that any changes in [Na]1 in that range might lead to a proportional reduction in agonist binding. In the next experiment, agonist binding to cells was studied in buffer containing 5 mM sodium and ouabain (30 itM) or monensin (0.1 itM). Under these conditions, [Na]1 increased from 5-6 to 23-33 nmol/mg. This [Na]1 corresponded to [Na]1 in the presence of 30 mM [Na]0. As shown in Fig. 6 , however, binding in the presence of these two agents was similar to that in control, whereas 30 mM sodium in the extracellular buffer inhibited binding significantly. Monensin is an electrically neutral antiporter and couples the transport of sodium with exchange of H~or K~in a number of systems (Rochdi et al., 1996) ; these neutral ionophores are also shown to transport cations against the concentration gradients ( Harris and Pressman, 1965, and references therein) . Under the present experimental conditions, monensin increased [Na] 1 with a simultaneous release of potassium ions. At 5 mM [Na]0, in the presence of ouabain and monensin, the intracellular potassium levels were 20-25% lower than control (223 ± 13 nmol/mg).
The next step was to study the binding in the presence of agents that are known to interact at the sodium binding sites. Agonist and antagonist binding was studied at various concentrations of EIPA, a potent amiloride analogue, and the results are presented in Fig. 7 To explore the effect of sodium further, we decided to study the signal transduction through the it receptor. Inhibition of adenylyl cyclase activity by DAMGO was studied in intact cells at various concentrations of sodium, and the results are presented in Table 2 . Forskolin-stimulated cyclic AMP levels were low in choline buffer (15.37 ± 2.02 pmol/min/mg) and were Values are means ±SEM (n = 4). Retinoic acid-differentiated SH-SY5Y cells were collected, washed with isotonic choline buffer, and used to measure DAMGO inhibition of forskolin-stimulated adenylyl cyclase activity. Cells were incubated at 37°Cfor 15 mm in buffers containing different concentrations of sodium, and cyclic AMP levels were estimated as described in Materials and Methods.
"p < 0.05, compared with 10 mM sodium group.
enhanced by increasing sodium concentration in the incubation buffer, by 30-40% in buffer containing 10 mM and >100% in the presence of 118 mM NaC1 (33.4 ±4.89 pmol/min/mg). DAMGO inhibited forskolin-stimulated adenylyl cyclase activity in choline buffer by 20-27% with an EC50 of 1.1 nM. Inclusion of 50 mM sodium brought about the maximal inhibition of forskolin-stimulated adenylyl cyclase activity by DAMGO, which was '-~85%under the experimental conditions, and the sigmoidicity of the curves improved with the gradual increments of sodium up to 118 mM in the assay buffer (Fig. 8) . The EC50 of attenuation of cyclic AMP levels by DAMGO increased slightly with increasing sodium concentrations, and the values obtained in buffers containing 0, 10, and 118 mM sodium (1.1, 4.30 ± 0.308, and 6.7 ±0.344 nM, respectively) were significantly different (p < 0.05). Cyclic AMP levels were also measured in buffer containing 34mM KC1 (i.e., under conditions that lead to a reduction in [Na]1), but the dose-response curves of DAMGO were not different from the control, as the EC50 and the maximal inhibition were 6.9 ± 3.25 nM and 82%, respectively. DAMGO inhibition of forskolin-stimulated cyclic AMP levels in the presence of 30 itM monensin was comparable to control (EC5O values of 10.5 ± 1.81 nM in control, 13.9 ± 1.19 nM with monensin), although forskolin stimulation of cyclic AMP levels increased significantly 10 mM (0), 50 mM (A), and 118 mM (LI). KCI (34 mM) was added to the incubation mixture to a set of tubes (.) . After 15 mm, the incubation was terminated and the cyclic AMP levels were estimated as given in Materials and Methods. The experiment was repeated three times, and the parameters are given in Table 2 . (53.7 ± 7.03 pmol/min/mg) (Fig. 9) . Cyclic AMP levels measured in the absence of forskolin were negligible in these assays.
DISCUSSION
A number of U protein-coupled receptors are modulated by sodium (Jakobs, 1979) . The exact mechanism by which sodium modulates the ligand binding, however, is not completely elucidated. Thus, the present studies were undertaken to study the effect of sodium chemical gradient across the neural membrane on opioid receptor-ligand interactions. These modulations are of particular significance, because the receptors are bathed in extracellular fluids containing high concentrations of sodium and sodium is reported to be essential for receptor-mediated signal transduction .
In the binding experiments conducted in intact cells, agonist binding and antagonist binding were changed differentially by sodium. Sodium-induced changes in binding were more prominent for the agonists, leading to =~70%reduction in the Bmax in the presence of 118 mM sodium, whereas antagonist binding showed only an increase in the binding affinity that was not very convenient to measure under different experimental conditions. Hence, all the binding studies reported herein employed DAMGO to study the effect of sodium on receptor-ligand interactions. Agonist binding to cells at various concentrations of sodium suggested that the modulation of sodium in cells was maximal under physiological conditions. Increasing the concentrations of sodium in the incubation buffer progressively raised [Na]1while inhibiting the agonist binding with an EC50 of 15 mM [Na]0 (Fig. 3) .
Cellular sodium levels are regulated mainly by the activities of Na + ,K + -ATPase and voltage-dependent sodium channels. The sodium pump maintains a constant electrochemical gradient for sodium by altering [Na] , in response to changes in membrane potential. In the present studies, addition of depolarizing concentrations of potassium led to >65% reduction in cellular sodium levels. If intracellular sodium has access to the "sodium site" on the receptor, this depletion in sodium levels would enhance the binding of an agonist to the receptor. It is surprising that [ 3H]DAMGO binding was not increased under these conditions, suggesting that the receptor is rather insensitive to the changes in [Na] 1.
In experiments designed to study the agonist bin'iing in cells with higher [Na] ,, at unaltered [N]0, ou~oain and monensin wer:: added independently aUd in combination to the ph~logical buffer. The presence of monensin brough~:b~uta dramatic increase in [Na]1 (from 53 to 240 lU Jmg), whereas ouabain increased [Na]1 to 120 nI': 1mg, presumably by blocking Na~,K~-ATPa~ẽ :ffluxof sodium. However, the increased levels~1 NU I, in the presence of either of these agents die ::ffect the agonist binding at all. [ 3H]DAMGO hIUhI1U measured in cells incubated in the presence of w Sin and ouabain at the concentration range of sod U at which agonist binding would be inhibited in a li::~:ar fashion (5-10mM [Na],,) also yielded similar results. These results show the lack of any regulation of agonist binding by intracellular sodium, in contrast to the earlier reports, which proposed a regulatory role for intracellular sodium (Motulsky and Insel, 1983; Puttfarcken et al., 1986) .
The role of sodium in the receptor-mediated adenylyl cyclase activity is yet another interesting aspect of the sodium effect. Although it was shown to be essential for the opiate-mediated inhibition of cyclic AMP levels , sodium-independent inhibition of adenylyl cyclase activity by the 6 receptor was also reported (Isom eta!., 1987) . In our studies, DAMGO inhibited the activity of forskolinstimulated adenylyl cyclase by 20-27% in choline buffer, but the maximal effect was attained only in the presence of 50 mM sodium. The potency of DAMGO was higher in 0 and 10 mM sodium buffers, because the precoupled high-affinity receptor is presumably the prevalent form in the absence of sodium (Thomsen et al., 1988; Costa et al., 1989) . The agonist potency in inhibiting adenylyl cyclase in these studies ranged from 1.1 to 6.8 nM, and this corresponded to the Kõ btained in binding studies, both measured in intact cells, indicating the importance of the high-affinity state of the receptor in signal transduction. In addition, sodium increased the stimulation of adenylyl cyclase activity by forskolin in these studies, whereas in NG 108-15 cells, prostaglandin E 1 and 2-chloro-adenosine stimulation of cyclic AMP levels were reported to be normal in the absence of sodium . Forskolin is known to exert its actions directly on adenylyl cyclase, as well as through the mediation of G. protein (Seamon et a!., 1981; Green and Clark, 1982) , and perhaps the direct interactions of forskolin with the enzyme are modulated by sodium. The dose-response curves of DAMGO at lower concentrations of sodium were hyperbolic, and a typical sigmoid curve was obtained only in the presence of buffer containing >50 mM sodium. In this respect, the sodium effect on the system can be viewed as that of a negative allosteric modulator that would increase the sensitivity of a system to make it physiologically useful. Furthermore, DAMGO attenuation of cyclic AMP levels did not change when measured in buffers containing 34 mM potassium (low [Na]1) or 30 itM monensin (high [Na] 1). Thus, these results show that signal transduction through the it receptor is also regulated by extracellular sodium.
To explore the nature of the sodium effect further, EIPA has been employed in the binding assays. Amilorides, in general, are known to bind to sodium binding sites and have been shown to interact with a2 receptors in plasma membranes from bovine aorta in a competitive, as well as noncompetitive, fashion (Jagadeesh et al., 1990) . In the same system, it was also suggested that the allosteric effects caused by amilorides were due to their interaction at the sodium site of action. In the present studies, naltrexone binding was inhibited by EIPA with a K, of 1.82 itM, which corresponds with the K1 of 1.6 itM for the inhibition of rauwolscine binding by EIPA in the above studies, whereas DAMGO binding was inhibited with a K, of 14.2 nM. This difference in the sensitivity of agonist and antagonist binding to EIPA corresponds closely to their sodium sensitivities. Sodium increased the affinity of naltrexone by threefold, whereas DAMGO affinity was reduced drastically and was manifested in a reduction in the total number of binding sites. In addition, the results may indicate that the sodium site is located closer to the agonist binding motif and, therefore, the agonist binding is more sensitive to EIPA. Amilorides have been shown to compete for the sodium binding sites in a variety of systems (Vigne et al., 1983) , and the effects of BIPA on ligand binding to the whole cells suggest the presence of the sodium site on the external surface of the cell.
It is interesting that SH-SY5Y cells exhibit considerable high-affinity binding of DAMGO in buffers containing physiological concentrations of sodium. Toll (1992) reported DAMGO binding to a single lowaffinity site (K, of 150 nM) in intact SH-SY5Y cells, on the basis of displacement assays using [ 3H]CTOP (3H-labeled Cys2 ,Tyr,Orn5 ,Pen7 amide), a peptide antagonist. This could be the result of using ligand concentrations that were too narrow to discern two affinity states with widely diverging KD values, because previous studies from our laboratory showed two sites with K 1 values of 3.90 and 161 nM for DAMGO in intact SH-SY5Y cells (Carter and Medzihradsky, 1992) . In addition, these high-affinity sites have been shown to be coupled to the U protein, as binding to these sites was found to be modulated by the endogenous guanosine triphosphate levels (Yabaluri and Medzihradsky, 1995) . Furthermore, it appears that there exist two sets of binding sites for DAMUO, because -~30%of the sites retain their high affinity, whereas 70% of the sites are converted into a low-affinity state in the presence of sodium. It is possible that sodium displaces agonist from these sites, as DAMGO can displace [ 3H]-naloxone binding completely in physiological buffers, albeit at higher concentrations. Allosteric binding sites for sodium on the receptor protein itself were first suggested for the a 2A-adrenergic system (Michel et al., 1980; Nunnari et a!., 1986) . In addition, site-directed mutagenesis experiments carried out on a variety of U protein-coupled receptors, including opioid receptors, provide important information in this regard. A highly conserved aspartate residue in the second transmembrane domain of the receptors, in general, has been shown to be important in imparting the sodium sensitivity on the G110-coupled receptors (Kong et a!., 1993a) . It is interesting that this residue (Asp 95) was implicated in the high-affinity binding of 6 receptorselective agonists to the cloned 6 receptor, which was coupled to U protein and attenuated the forskolin-stimulated adenylyl cyclase activity (Kong et a!., 1993b) . This might suggest that the sodium site is closer to the agonist binding motif, as mentioned earlier in this report. This highly conserved aspartate was identified as a key residue in the agonist-induced receptor activation of not only the it receptor (Surratt et a!., 1994), but also muscaninic acetylcholine receptors (Fraser et a!., 1989) , f3-adrenergic receptor (Strader et a!., 1988) , a 2A-adrenergic receptors (Wang et a!., 1991) , and lutropin receptor (Ji and Ji, 1991) . In the present studies, the affinity of the antagonist was improved by sodium, whereas the number of sites was not changed. Naltrexone may bind to the same set of binding sites as DAMGO (in choline buffer), but sodium interaction may somehow stabilize the antagonist binding, thereby increasing the affinity. In contrast, antagonists may bind to totally different domains and displace agonist binding as a result of a general conformational change (Neve et a!., 1990; Kong et a!., 1994) .
The results presented in this report are contradictory to what has been observed in 7315c cells by Puttfarcken et al. (1986) . In these cells, experiments with monensin indicated the presence of the sodium site on the intracellular side. In addition, it was shown that sodium reduced the affinity of the~receptor without affecting the maximal number of binding sites. The sodium effect on agonist-receptor interactions is known to vary for individual ligands (Pert et al., 1973) . Although the radioligand used in our studies ([ 3H] DAMGO) binds to the high-affinity receptor, [3H] etorphine employed in those studies detects the low-affinity sites. Thus, etorphine binding showed only an increase in KD as a result of conversion of highaffinity sites into a low-affinity form by sodium, whereas DAMGO failed to detect the low-affinity sites and, as a result, there was a reduction in the total number of binding sites in saturation experiments. However, the reasons for the differences in the experiments using mor 'snsin are not clear. The discrepancy could be due to the fact that the 7315c cells used in those studies were not from any stableS cell line and were obtained by dispersal of solid tumor masses. In the present studies, the effects observed were reproducible in three cell lines, namely, undifferentiated and retinoic acid-differentiated SH-SY5Y cells and C6it5 cells. In contrast, these differences may indicate the importance of the ambient environment on receptor-ligand interactions as reported in the case of cannabinoid receptors (Pacheco et a!., 1994) .
Although an intracellular site of action was first proposed in platelets (Motulsky and Insel, 1983) , the results therein leave many questions unanswered. In the same studies, although the ability of epinephrine to attenuate prostaglandin E 1-stimu!ated cyclic AMP accumulation was comparable in platelets prepared in the presence or absence of sodium, only the platelet aggregation was shown to be affected by the internal pools of sodium (Connolly and Limbird, 1983) . Moreover, this function was independent of U protein activation by pertussis toxin. It is possible that the mechanism of action for the aggregation of platelets is entirely different from the receptor-mediated attenuation of adenylyl cyclase activity. It should also be mentioned that accumulation of sodium per se was shown not to be sufficient to induce platelet aggregation (Feinberg et a!., 1977) .
Thus, the data presented in this report clearly demonstrate the extracellular site of action for sodium.
[Na]1 was manipulated in both directions, and the experiments with monensin, ouabain, and EIPA all point to the regulation of ligand binding by extracellular sodium. These studies also show the importance of the sodium ion in signal transduction through ther eceptor.
